Skip to content

Vascular Effect of Tibolone Versus Placebo Evaluated by Flow-mediated Dilatation of Brachial Artery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01679795
Enrollment
60
Registered
2012-09-06
Start date
2012-02-29
Completion date
2015-02-28
Last updated
2015-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Flow-mediated Dilation Evaluation of the Brachial Artery

Keywords

hormone replacement therapy; Dopplervelocimetry; Flow-mediated dilation; menopause; tibolone

Brief summary

The aim of this study is to evaluate the vascular effects of tibolone on climateric women measured by flow-mediated evaluation of the brachial artery using high resolution ultrasound and compare to placebo.

Interventions

DRUGPlacebo

Sponsors

Federal University of Minas Gerais
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
50 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Women without menstrual cycles whithin the last 12 months and FSH\>30IU/L * Healthy women * Women that were not using drugs with potential vascular effect whithin the last 1 year * Women that never used hormone replacement therapy

Exclusion criteria

* Smoking * Blood Pressure \> 160/90 mm Hg. * Breast and or endometrial cancer * History of acute myocardial infarction * Diabetes * Vaginal bleeding of any origin * Hepatic disease * thrombophlebitis or thromboembolic disorders

Design outcomes

Primary

MeasureTime frameDescription
Flow-mediated dilation of the brachial artery one month after treatment started Flow-mediated dilation of the brachial artery one month after treatment started Flow-mediated dilation of the brachial artery30 daysFlow-mediated dilation will be measured by high resolution ultrasound

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026